CBD Global Revenue vs. Current Valuation
| CBDNFDelisted Stock | USD 0.06 0.00 0.00% |
For CBD Global profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CBD Global to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CBD Global Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CBD Global's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CBD Global Sciences over time as well as its relative position and ranking within its peers.
CBD |
CBD Global Sciences Current Valuation vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining CBD Global's current stock value. Our valuation model uses many indicators to compare CBD Global value to that of its competitors to determine the firm's financial worth. CBD Global Sciences is rated fifth in revenue category among its peers. It is rated third in current valuation category among its peers reporting about 86.49 of Current Valuation per Revenue. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CBD Global's earnings, one of the primary drivers of an investment's value.CBD Revenue vs. Competition
CBD Global Sciences is rated fifth in revenue category among its peers. Market size based on revenue of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 38.63 Billion. CBD Global adds roughly 166,947 in revenue claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
CBD Current Valuation vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
CBD Global |
| = | 166.95 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
CBD Global |
| = | 14.44 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CBD Current Valuation vs Competition
CBD Global Sciences is rated third in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 4.7 Billion. CBD Global adds roughly 14.44 Million in current valuation claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
CBD Global Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in CBD Global, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CBD Global will eventually generate negative long term returns. The profitability progress is the general direction of CBD Global's change in net profit over the period of time. It can combine multiple indicators of CBD Global, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
CBD Global Sciences Inc. engages in cannabidiol farming, processing, and product manufacturing business. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado. Cbd Global operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
CBD Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on CBD Global. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CBD Global position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CBD Global's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in CBD Global without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Use Investing Themes to Complement your CBD Global position
In addition to having CBD Global in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Warren Buffett Holdings Thematic Idea Now
Warren Buffett Holdings
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in CBD Pink Sheet
If you are still planning to invest in CBD Global Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CBD Global's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |